Patheon plant in France gets FDA OK; FDA wants comments on track-and-trace;

> Texas-based Pernix Therapeutics is selling a manufacturing plant in Houston to Woodfield Pharmaceutical to reduce costs and expects to net about $1.2 million. Release

> The FDA has issued a warning letter to compounder Pentec Health in Boothwyn, PA, for unsanitary processes when making sterile drugs. Letter

> The FDA has approved a Patheon plant in Bourgoin, France, to make solid oral forms and nonsterile liquid medications. Release

> The FDA has issued an import ban on a Marck Biosciences plant in Gujarat, India. Alerts

> Impax Laboratories, which has had manufacturing problems that have prevented it from getting its extended-release Parkinson's drug Rytary to market, has named Jeffrey D. Nornhold as senior vice president, technical operations. Release

And Finally... The FDA is seeking comments on implementing a national track-and-trace system. Article